Irbesartan Torrent Pharma (Uk)

Irbesartan, the active ingredient in Irbesartan Torrent Pharma (Uk), is an Angiotensin II receptor blocker (ARB) presented as an oral dosage form for oral use. It is prescribed to lower high blood pressure and to protect kidney function in patients with diabetic kidney disease.

GNH USA supplies Irbesartan Torrent Pharma (Uk) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution, ensuring reliable supply to healthcare providers.

Irbesartan is an Angiotensin II receptor blocker used to manage conditions related to the renin‑angiotensin system.

Hypertension: reduces elevated blood pressure by blocking angiotensin II, helping lower cardiovascular risk. Diabetic nephropathy: slows progression of kidney damage in type 2 diabetes by decreasing intraglomerular pressure. Proteinuria: decreases urinary protein excretion in patients with diabetic kidney disease, supporting renal protection.

Irbesartan may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: feeling light‑headed or unsteady. - Headache: mild to moderate pain. - Hyperkalemia: elevated blood potassium levels.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue or throat. - Acute renal failure: sudden loss of kidney function. - Hepatic injury: abnormal liver enzymes or hepatitis.

When prescribing Irbesartan, clinicians should observe several safety considerations. - Monitor blood pressure: ensure target reduction without excessive hypotension. - Assess renal function: check serum creatinine and eGFR before and during therapy. - Check serum potassium: avoid hyperkalemia, especially with potassium‑sparing agents. - Use caution in severe hepatic impairment: dose adjustment may be required. - Avoid use in pregnancy: drug may harm the fetus. - Store at room temperature: keep in original packaging, protect from moisture.

Irbesartan can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of hyperkalemia. - ACE inhibitors: additive effect on potassium and renal function. - Aliskiren in diabetic patients: heightened risk of renal impairment.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive response and affect kidney function. - Lithium: can raise lithium concentrations, risking toxicity. - Non‑potassium‑sparing diuretics: may enhance hypotensive effect.